title: The effect of stage of growth and implant exposure on performance and carcass composition in steers.
abstract: Angus and Angus x Limousin cross steers (n = 182; initial BW = 309 +/- 27.8 kg) were used to evaluate the influence of an estradiol-trenbolone acetate implant (containing 24 mg of estradiol and 125 mg of trenbolone acetate) on production efficiency and carcass traits when administered at specific stages of growth. Treatments were 1) control, no implant (NI); 2) early implant (EI) on d 1 (BW = 309 kg); or 3) delayed implant (DI) on d 57 (BW = 385 kg). Comparisons were also made between the NI and implanted treatments (I; EI + DI). Steers were procured at weaning and were backgrounded (47 d) before the initiation of the experiment. Initial predicted carcass composition was 14.9% protein, 13.3% fat, 54.6% moisture, and 17.2% bone. Days on feed were constant across treatment. After 56 d, ADG and G:F were improved (P < 0.01) by implants, NI vs. EI (1.68 vs. 1.90 kg and 0.227 vs. 0.257). At d 57, predicted carcass composition did not differ among treatments. From 57 to 112 d, DI caused higher ADG than NI or EI (NI = 1.65, EI = 1.57, and DI = 1.78 kg; P < 0.05) and higher G:F (NI = 0.155, EI = 0.150, and DI = 0.173; P < 0.01). Cumulative ADG and G:F were improved by implants (1.65 vs. 1.73 kg; P < 0.05) and (0.175 vs. 0.186; P < 0.01) for NI vs. I, respectively, with no differences between treatments that involved implants. Cumulative DMI was similar for all treatments. Implanting increased dressing percentage (63.5 vs. 64.1%; P < 0.05) and increased (P < 0.01) hot carcass weight (341 vs. 353 kg) and LM area (76.5 vs. 81.4 cm(2)) for NI vs. I, respectively. Rib fat and kidney, pelvic, and heart fat were not affected by treatment, and treatment had no effect on the whole carcass proportions of fat, protein, or water. Implants advanced maturity scores (NI = A(51) vs. EI + DI = A(59); P < 0.01). Marbling scores were decreased (P < 0.05) by EI but not by DI (NI = Small(65), EI = Small(20), DI = Small(36)). The percentage of i.m. fat content of the LM was decreased (P < 0.10) by EI and was not affected by DI (NI = 5.1, EI = 4.0, DI = 4.8%). Treatment affected (P < 0.10) the proportion of carcasses with marbling scores greater than Modest(0) (NI = 23.6, EI = 7.8, DI = 22.6%). The results of this study suggest that growth of i.m. fat is sensitive to anabolic growth promotants administered during early periods of growth.
authors.affiliation: Department of Animal and Range Sciences, South Dakota State University, Brookings 57007, USA. kelly_bruns@sdstate.edu <kelly_bruns@sdstate.edu>
authors.forename: K W
authors.initials: KW
authors.lastname: Bruns
authors.forename: R H
authors.initials: RH
authors.lastname: Pritchard
authors.forename: D L
authors.initials: DL
authors.lastname: Boggs
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects; D045930:Anabolic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000822:Animal Husbandry; D000818:Animals; D001823:Body Composition / Q000187:drug effects*; D050218:Body Fat Distribution / Q000662:veterinary; D001835:Body Weight / Q000187:drug effects; D002417:Cattle / Q000254:growth & development*; D004338:Drug Combinations; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D016014:Linear Models; D008297:Male; D008460:Meat / Q000592:standards; D011897:Random Allocation; D013997:Time Factors; D014204:Trenbolone Acetate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D045930:Anabolic Agents; D004338:Drug Combinations; D004343:Drug Implants; D004958:Estradiol; D014204:Trenbolone Acetate